TY - JOUR
T1 - Outcomes of early endoscopic intervention for pancreatic necrotic collections
T2 - a matched case-control study
AU - Oblizajek, Nicholas
AU - Takahashi, Naoki
AU - Agayeva, Sevda
AU - Bazerbachi, Fateh
AU - Chandrasekhara, Vinay
AU - Levy, Michael
AU - Storm, Andrew
AU - Baron, Todd
AU - Chari, Suresh
AU - Gleeson, Ferga C.
AU - Pearson, Randall
AU - Petersen, Bret T.
AU - Vege, Santhi Swaroop
AU - Lennon, Ryan
AU - Topazian, Mark
AU - Abu Dayyeh, Barham K.
N1 - Funding Information:
DISCLOSURE: Dr Chandrasekhara has served on a medical advisory board for Interpace Diagnostics and is a shareholder in Nevakar Corp. Dr Storm has been a consultant for GI Dynamics and has received research support from Endo-TAGSS, Boston Scientific, Apollo Endosurgery. Dr Baron has served as a consultant and speaker for BSCI, Cook Endoscopy, Olympus, W.L. Gore, and Medtronic. Dr Petersen has served as an investigator and consultant for Boston Scientific and as a consultant for Olympus America, Pentax, Inc, GIE Medical, and AMBU. Dr Vege has written for UpToDate and was involved as an investigator in the NIH CPPDC consortium trial. Dr Abu Dayyeh has served as a consultant for Boston Scientific, Metamodix, BFKW, DyaMx, and USGI Medical, has received research support for Boston Scientific, Apollo Endosurgery, USGI, Spatz Medical, GI Dynamics, Caim Diagnostics, Aspire Bariatrics, and Medtronic, and has been a speaker for Johnson & Johnson, Endogastric Solutions, and Olympus. The other authors disclosed no financial relationships.
Publisher Copyright:
© 2020 American Society for Gastrointestinal Endoscopy
PY - 2020/6
Y1 - 2020/6
N2 - Background and Aims: Pancreatic necrosis may be categorized as an acute necrotic collection (ANC) or walled-off necrosis (WON) based on complete encapsulation by a wall and collection age (≤4 weeks or >4 weeks). Endoscopic intervention of WON has become the standard of care, but little is known regarding the safety and efficacy of endoscopic intervention of pancreatic necrosis ≤4 weeks from disease onset. Methods: Retrospective review of medical records and imaging studies of all patients undergoing early endoscopic intervention of pancreatic necrosis between 2008 and 2018 was carried out at 1 referral center. Patients who underwent previous interventional treatment were excluded. Control WON patients were matched to early intervention cases. The primary outcome was defined as resolution of the collection after endoscopic treatment, without surgery. Results: Nineteen patients with early intervention were identified. The most common indication for intervention was infection. Median age of these collections at the time of initial endoscopic intervention was 23 days (range, 15-27 days), and all collections had a partial or complete wall discernable on contrast-enhanced CT. Eleven patients underwent concurrent endoscopic necrosectomy. The primary outcome was achieved in all patients in the early intervention group. Total duration of therapy was longer for early intervention compared with controls (103 vs 69 days, P = .042), with no mortality and similar adverse event rates compared with controls. Conclusions: Endoscopic intervention of pancreatic necrosis in the third and fourth weeks of illness appears effective and safe when a partial collection wall is present on cross-sectional imaging studies, with outcomes paralleling those reported for intervention of WON.
AB - Background and Aims: Pancreatic necrosis may be categorized as an acute necrotic collection (ANC) or walled-off necrosis (WON) based on complete encapsulation by a wall and collection age (≤4 weeks or >4 weeks). Endoscopic intervention of WON has become the standard of care, but little is known regarding the safety and efficacy of endoscopic intervention of pancreatic necrosis ≤4 weeks from disease onset. Methods: Retrospective review of medical records and imaging studies of all patients undergoing early endoscopic intervention of pancreatic necrosis between 2008 and 2018 was carried out at 1 referral center. Patients who underwent previous interventional treatment were excluded. Control WON patients were matched to early intervention cases. The primary outcome was defined as resolution of the collection after endoscopic treatment, without surgery. Results: Nineteen patients with early intervention were identified. The most common indication for intervention was infection. Median age of these collections at the time of initial endoscopic intervention was 23 days (range, 15-27 days), and all collections had a partial or complete wall discernable on contrast-enhanced CT. Eleven patients underwent concurrent endoscopic necrosectomy. The primary outcome was achieved in all patients in the early intervention group. Total duration of therapy was longer for early intervention compared with controls (103 vs 69 days, P = .042), with no mortality and similar adverse event rates compared with controls. Conclusions: Endoscopic intervention of pancreatic necrosis in the third and fourth weeks of illness appears effective and safe when a partial collection wall is present on cross-sectional imaging studies, with outcomes paralleling those reported for intervention of WON.
UR - http://www.scopus.com/inward/record.url?scp=85083014636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083014636&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2020.01.017
DO - 10.1016/j.gie.2020.01.017
M3 - Article
C2 - 31958461
AN - SCOPUS:85083014636
SN - 0016-5107
VL - 91
SP - 1303
EP - 1309
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 6
ER -